Up | AC
Home Page
Food and
Drug Administration
Blood Products Advisory Committee
April 1 & 2, 2009
BRIEFING INFORMATION
FDA
Topic I.A
Blood Donor Screening for Hepatitis B Virus Infection by Nucleic Acid Testing (htm)
Topic I.B
Testing donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) for hepatitis B virus infection by nucleic acid testing (htm)
Topic II
Potential Testing Strategies for T. cruzi Infection in Blood Donors (htm)
Topic III
Current Considerations on Plasma Obtained from Whole Blood Donors for Further Manufacturing Use (htm)
REFERENCES (htm)